Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study
نویسندگان
چکیده
منابع مشابه
Intraocular lymphoma in Korea: the Consortium for Improving Survival of Lymphoma (CISL) study
BACKGROUND Intraocular lymphoma (IOL) is a rare malignant lymphoma that most closely resembles a diffuse large B-cell lymphoma, and it is a subtype of primary central nervous system lymphoma (PCNSL). IOL is located inside the eye in the retina, uvea, and/or optic nerve. We retrospectively analyzed IOL patient data to identify treatment patterns and survival rates in Korea. METHODS Cytological...
متن کاملConsortium for Improving Survival of Lymphoma (CISL): a model of multicenter collaboration for lymphoma studies in Korea
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Lymphoma is the most common hematologic malignancy, accounting for more than 40% of hematologic malignancies in Korea [1]. However, lymphoma is not a single disorder but a heterogeneous group of subtypes that arise from abnormal B cells or T/NK cells at vari...
متن کاملThe Consortium for Improving Survival of Lymphoma (CISL): recent achievements and future perspective
The Consortium for Improving Survival of Lymphoma (CISL) of the Korean Society of Hematology Lymphoma Working Party is a multicenter collaborative study group performing prospective clinical studies for lymphoma patients and retrospective analyses. Since 2006, the CISL has performed >35 prospective clinical trials and >30 retrospective studies to investigate the clinical and pathological featur...
متن کاملPrognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)
BACKGROUND The objective of this study was to identify prognostic factors for survival in patients with primary diffuse large B-cell lymphoma (DLBCL) of the adrenal gland. METHODS Thirty one patients diagnosed with primary adrenal DLBCL from 14 Korean institutions and treated with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone) were analyzed. RESULTS Complete r...
متن کاملAuthor's response to reviews Title: Multicenter retrospective analysis of 581 patients with primary intestinal non-Hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL) Authors:
Seok Jin Kim ([email protected]) Chul Won Choi ([email protected]) Yeung-Chul Mun ([email protected]) Sung Yong Oh ([email protected]) Hye Jin Kang ([email protected]) Soon Il Lee ([email protected]) Jong-Ho Won ([email protected]) Min Kyoung Kim ([email protected]) Jung Hye Kwon ([email protected]) Jin Seok Kim ([email protected]) Jae-Yong Kwak ([email protected]) Jung Mi Kwon (aseve...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood Research
سال: 2015
ISSN: 2287-979X,2288-0011
DOI: 10.5045/br.2015.50.4.242